These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. A double-blind randomized controlled trial of fusidic acid and metronidazole for treatment of an initial episode of Clostridium difficile-associated diarrhoea. Wullt M, Odenholt I. J Antimicrob Chemother; 2004 Jul; 54(1):211-6. PubMed ID: 15163651 [Abstract] [Full Text] [Related]
13. Antimicrobial activity of LFF571 and three treatment agents against Clostridium difficile isolates collected for a pan-European survey in 2008: clinical and therapeutic implications. Debast SB, Bauer MP, Sanders IM, Wilcox MH, Kuijper EJ, ECDIS Study Group. J Antimicrob Chemother; 2013 Jun 25; 68(6):1305-11. PubMed ID: 23420839 [Abstract] [Full Text] [Related]
14. Molecular characterization of Clostridium difficile isolates from horses in an intensive care unit and association of disease severity with strain type. Magdesian KG, Dujowich M, Madigan JE, Hansen LM, Hirsh DC, Jang SS. J Am Vet Med Assoc; 2006 Mar 01; 228(5):751-5. PubMed ID: 16506942 [Abstract] [Full Text] [Related]
15. Correlation of disease severity with fecal toxin levels in patients with Clostridium difficile-associated diarrhea and distribution of PCR ribotypes and toxin yields in vitro of corresponding isolates. Akerlund T, Svenungsson B, Lagergren A, Burman LG. J Clin Microbiol; 2006 Feb 01; 44(2):353-8. PubMed ID: 16455883 [Abstract] [Full Text] [Related]
16. The incidence of nosocomial toxigenic clostridium difficile associated diarrhea in Tehran tertiary medical centers. Sadeghifard N, Salari MH, Ghassemi MR, Eshraghi S, Amin Harati F. Acta Med Iran; 2010 Feb 01; 48(5):320-5. PubMed ID: 21287466 [Abstract] [Full Text] [Related]
17. The epidemiology of Clostridium difficile in Scotland. Wiuff C, Brown DJ, Mather H, Banks AL, Eastaway A, Coia JE. J Infect; 2011 Apr 01; 62(4):271-9. PubMed ID: 21300104 [Abstract] [Full Text] [Related]
18. Outcomes of Clostridium difficile-associated disease treated with metronidazole or vancomycin before and after the emergence of NAP1/027. Pépin J, Valiquette L, Gagnon S, Routhier S, Brazeau I. Am J Gastroenterol; 2007 Dec 01; 102(12):2781-8. PubMed ID: 17900327 [Abstract] [Full Text] [Related]